|
|
skeletal system development
|
GO:0001501 |
356 |
0.921
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.715
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.687
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.630
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.553
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.442
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.440
|
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.427
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.424
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.418
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.416
|
|
|
|
bone maturation
|
GO:0070977 |
13 |
0.395
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.383
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.376
|
|
|
|
ossification involved in bone maturation
|
GO:0043931 |
12 |
0.350
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.336
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.328
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.319
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.310
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.307
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.303
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.298
|
|
|
|
positive regulation of immature t cell proliferation
|
GO:0033091 |
4 |
0.297
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.297
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.295
|
|
|
|
replacement ossification
|
GO:0036075 |
26 |
0.291
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.279
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.273
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.271
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.265
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.261
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.260
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.258
|
|
|
|
left lung development
|
GO:0060459 |
4 |
0.256
|
|
|
|
dorsal ventral axon guidance
|
GO:0033563 |
3 |
0.255
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.249
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.246
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.244
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.243
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.240
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.235
|
|
|
|
organ maturation
|
GO:0048799 |
17 |
0.222
|
|
|
|
deltoid tuberosity development
|
GO:0035993 |
3 |
0.215
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.206
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.204
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.201
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.199
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.196
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.196
|
|
|
|
positive regulation of mesenchymal cell proliferation involved in ureter development
|
GO:2000729 |
3 |
0.190
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.188
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.186
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.181
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.180
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.178
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.176
|
|
|
|
tube lumen cavitation
|
GO:0060605 |
5 |
0.173
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.171
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.171
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.171
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.171
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.169
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.168
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.168
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.167
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.166
|
|
|
|
extraocular skeletal muscle development
|
GO:0002074 |
2 |
0.163
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.163
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.163
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.162
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.161
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.159
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.158
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.157
|
|
|
|
negative regulation of dna templated transcription elongation
|
GO:0032785 |
6 |
0.156
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.155
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.155
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.154
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.153
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.151
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.148
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.148
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.146
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.145
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.144
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.143
|
|
|
|
positive regulation of dopamine uptake involved in synaptic transmission
|
GO:0051586 |
2 |
0.143
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.143
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.142
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.141
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.141
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
63 |
0.141
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.140
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.139
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.138
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.137
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.137
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.137
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.135
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.135
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.135
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.133
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.133
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.132
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.132
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.130
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.129
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.127
|
|
|
|
endodermal digestive tract morphogenesis
|
GO:0061031 |
4 |
0.126
|
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.123
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.123
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.123
|
|
|
|
ventricular zone neuroblast division
|
GO:0021847 |
3 |
0.121
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.121
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.121
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.120
|
|
|
|
branchiomeric skeletal muscle development
|
GO:0014707 |
3 |
0.118
|
|
|
|
cell proliferation involved in outflow tract morphogenesis
|
GO:0061325 |
4 |
0.118
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.117
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.117
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.114
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.113
|
|
|
|
prostate gland morphogenetic growth
|
GO:0060737 |
4 |
0.112
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.112
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.111
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.111
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.110
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.109
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.109
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.109
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.108
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.108
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.107
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.107
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.106
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.105
|
|
|
|
catecholamine uptake
|
GO:0090493 |
4 |
0.105
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.103
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.102
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.102
|
|
|
|
gonad morphogenesis
|
GO:0035262 |
1 |
0.102
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.101
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.101
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.101
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.100
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.100
|
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.098
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.098
|
|
|
|
cell proliferation in external granule layer
|
GO:0021924 |
10 |
0.097
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.097
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.097
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.097
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.096
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.095
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.095
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.095
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.094
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.092
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.092
|
|
|
|
regulation of catecholamine uptake involved in synaptic transmission
|
GO:0051940 |
2 |
0.091
|
|
|
|
anterior commissure morphogenesis
|
GO:0021960 |
6 |
0.091
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.091
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.091
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.091
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.091
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.091
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.090
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.090
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.089
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.089
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.089
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.088
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.088
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.087
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.086
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.086
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.086
|
|
|
|
tyrosine phosphorylation of stat1 protein
|
GO:0042508 |
3 |
0.086
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.084
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.084
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.084
|
|
|
|
left lung morphogenesis
|
GO:0060460 |
3 |
0.083
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.083
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.082
|
|
|
|
prostate epithelial cord elongation
|
GO:0060523 |
3 |
0.082
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.082
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.082
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.082
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.081
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.081
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.080
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.078
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.078
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.078
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.078
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.077
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.077
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.077
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.076
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.076
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.076
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.076
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.074
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.074
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.074
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.074
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.073
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.073
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.072
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.072
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.072
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.072
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.072
|
|
|
|
cardiac neural crest cell migration involved in outflow tract morphogenesis
|
GO:0003253 |
3 |
0.072
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.071
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.071
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.071
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.071
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.071
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.070
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.070
|
|
|
|
catecholamine secretion
|
GO:0050432 |
15 |
0.070
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.070
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.070
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.069
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.069
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.069
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.068
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.068
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.068
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.067
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.067
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.067
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.067
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.067
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.066
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.066
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.066
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.066
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.066
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.066
|
|
|
|
mammary gland bud morphogenesis
|
GO:0060648 |
4 |
0.065
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.065
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.064
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.064
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.064
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.063
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.062
|
|
|
|
positive regulation of epithelial cell differentiation involved in kidney development
|
GO:2000698 |
2 |
0.062
|
|
|
|
mesenchymal cell proliferation involved in ureter development
|
GO:0072198 |
4 |
0.062
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.062
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.062
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.062
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.062
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.061
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.061
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.060
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.060
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.059
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.058
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.058
|
|
|
|
positive regulation of fibroblast growth factor receptor signaling pathway
|
GO:0045743 |
3 |
0.058
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.058
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.058
|
|
|
|
salivary gland cavitation
|
GO:0060662 |
5 |
0.058
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.057
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.057
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.056
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
52 |
0.056
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.056
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.056
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.056
|
|
|
|
regulation of smoothened signaling pathway
|
GO:0008589 |
58 |
0.055
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.055
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.054
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.054
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.054
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.054
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.053
|
|
|
|
spinal cord motor neuron migration
|
GO:0097476 |
4 |
0.053
|
|
|
|
branching involved in salivary gland morphogenesis
|
GO:0060445 |
26 |
0.053
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.053
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.053
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.053
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.052
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.052
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.052
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.052
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.052
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.052
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.052
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.052
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.052
|
|
|
|
regulation of synapse structural plasticity
|
GO:0051823 |
4 |
0.052
|
|
|
|
positive regulation of catecholamine uptake involved in synaptic transmission
|
GO:0051944 |
2 |
0.052
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.052
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.052
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.051
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.051
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.051
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.051
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.051
|
|
|
|
positive regulation of growth hormone secretion
|
GO:0060124 |
3 |
0.051
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.051
|
|
|
|
regulation of stem cell division
|
GO:2000035 |
4 |
0.051
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.051
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.050
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.050
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.050
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.049
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.049
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.049
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.048
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.048
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.048
|
|
|
|
mammary placode formation
|
GO:0060596 |
4 |
0.048
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.048
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.048
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.048
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.048
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.047
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.047
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.047
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.047
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
45 |
0.047
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.047
|
|
|
|
cerebral cortex neuron differentiation
|
GO:0021895 |
19 |
0.047
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.046
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.046
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.046
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.046
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.046
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.046
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.045
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.045
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.045
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.045
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.045
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.045
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.045
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.044
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.044
|
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.044
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.044
|
|
|
|
regulation of catecholamine secretion
|
GO:0050433 |
12 |
0.044
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.044
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.044
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.044
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.043
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.043
|
|
|
|
response to inactivity
|
GO:0014854 |
4 |
0.043
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.043
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.043
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.043
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.043
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.043
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.043
|
|
|
|
negative regulation of lyase activity
|
GO:0051350 |
1 |
0.043
|
|
|
|
negative regulation of immature t cell proliferation
|
GO:0033087 |
3 |
0.043
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.042
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.042
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.042
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.042
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.042
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.042
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.042
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.041
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.041
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.041
|
|
|
|
endodermal cell fate determination
|
GO:0007493 |
2 |
0.041
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.041
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.041
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.041
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.041
|
|
|
|
regulation of cell proliferation in bone marrow
|
GO:0071863 |
2 |
0.041
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.041
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.041
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.040
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.040
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.040
|
|
|
|
regulation of dopamine uptake involved in synaptic transmission
|
GO:0051584 |
2 |
0.040
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.040
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.040
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.040
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.040
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.040
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
37 |
0.039
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.039
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.039
|
|
|
|
negative regulation of cellular catabolic process
|
GO:0031330 |
47 |
0.039
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.039
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.039
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.039
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.039
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.038
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.038
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.038
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.038
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.038
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.038
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.038
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.038
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.038
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.037
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.037
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.037
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.037
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.037
|
|
|
|
thermosensory behavior
|
GO:0040040 |
1 |
0.037
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.037
|
|
|
|
eye pigmentation
|
GO:0048069 |
3 |
0.036
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.036
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.036
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.036
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.036
|
|
|
|
positive regulation of steroid biosynthetic process
|
GO:0010893 |
4 |
0.036
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.036
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.036
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.036
|
|
|
|
primary prostatic bud elongation
|
GO:0060516 |
2 |
0.036
|
|
|
|
determination of heart left right asymmetry
|
GO:0061371 |
48 |
0.036
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.036
|
|
|
|
negative regulation of cardiac chamber morphogenesis
|
GO:1901220 |
2 |
0.035
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.035
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.035
|
|
|
|
positive regulation of neural precursor cell proliferation
|
GO:2000179 |
42 |
0.035
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.035
|
|
|
|
cellular response to lithium ion
|
GO:0071285 |
10 |
0.035
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.035
|
|
|
|
positive regulation of insulin secretion
|
GO:0032024 |
26 |
0.035
|
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.035
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.035
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.035
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.034
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.034
|
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.034
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.034
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.034
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.034
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.034
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.034
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.034
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.034
|
|
|
|
pulmonary myocardium development
|
GO:0003350 |
3 |
0.034
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.034
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
41 |
0.034
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.033
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.033
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.033
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.033
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.033
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.033
|
|
|
|
granulocyte colony stimulating factor production
|
GO:0071611 |
1 |
0.033
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.033
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.033
|
|
|
|
lateral motor column neuron migration
|
GO:0097477 |
3 |
0.033
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.033
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.033
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.033
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.033
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.033
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.033
|
|
|
|
neural crest cell migration
|
GO:0001755 |
32 |
0.033
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.033
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.033
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.033
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.033
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.033
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.033
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.032
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
29 |
0.032
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.032
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.032
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.032
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.032
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.032
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.032
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.032
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.032
|
|
|
|
mesodermal cell migration
|
GO:0008078 |
4 |
0.032
|
|
|
|
dopamine uptake involved in synaptic transmission
|
GO:0051583 |
4 |
0.032
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.032
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.032
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.032
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.032
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.031
|
|
|
|
positive regulation of hh target transcription factor activity
|
GO:0007228 |
3 |
0.031
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.031
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.031
|
|
